Innate Repair Limited (IR Ltd.) is a biotech spin-off from the Technische Universitaet Dresden (TUD) with the aim of translating novel scientific concepts generated at TUD into commercially successful therapies for the treatment of cancer and degenerative diseases including diabetes. IR Ltd. was initially founded in Great Britain as Limited, as there was the possibility of seed funding from British investors. Innate Repair operates in Dresden as Innate Repair Saxony GmbH (IRSN). IR Ltd. is focussing in Great Britain on the research and development of new treatments for aggressive brain tumours, while the IRSN in Dresden works on pancreas regeneration relevant for diabetes.